Loading research…
Beximco Pharmaceuticals Plc (DSEBD: BXPHARMA)
Beximco Pharmaceuticals Plc trades on DSEBD under the symbol BXPHARMA, quoted in BDT. The listing is associated with Bangladesh. Its sector is Health technology, within Pharmaceuticals: major. Reported figures retain their financial periods. Market prices and charts are shown separately from dated research.
- Exchange
- DSEBD
- Country
- Bangladesh
- Sector
- Health technology
- Industry
- Pharmaceuticals: major
- Trading currency
- BDT
- ISIN
- BD0453BXPH04
Reported financials
Research date October 28, 2026. Figures below are dated observations, not market quotes.
| Metric | Value | Period | Period end |
|---|---|---|---|
| Revenue | 437,612,387.34 USD | TTM | Mar 31, 2026 |
| Net income | 70,191,232.87 USD | TTM | Mar 31, 2026 |
| Diluted EPS | 0.16 USD | TTM | Mar 31, 2026 |
| Total assets | 594,328,158.94 USD | Annual | Jun 30, 2025 |
| Total debt | 40,292,021.31 USD | Annual | Jun 30, 2025 |
| Gross margin | 48.12% | TTM | Mar 31, 2026 |
| Operating margin | 21.01% | TTM | Mar 31, 2026 |
| Return on equity | 15.52% | TTM | Mar 31, 2026 |
| Return on assets | 11.26% | TTM | Mar 31, 2026 |
| Dividend per share | 0.04 USD | Annual | Jun 30, 2025 |
Stock ScreenerEarnings CalendarDividends CalendarStock investing guide
Data notes
Scores, valuation models and research metrics use dated FOLITIC research. Dates and currencies remain attached to their observations. Missing values are shown as a dash.
Market quotes and charts use the separate market-data display. Saved research prices and model comparisons are not live quotes. Model ranges represent sensitivity scenarios, not confidence intervals or price guarantees.
Listings on different exchanges and different share classes are kept separate. No currency conversion is applied to saved research values.